Substance use is a leading cause of burden of disease worldwide. Selective prevention programs can help reduce the development of problematic substance use a…
Medical marijuana for management of cancer pain: a narrative review.
The increasing legalization of medical marijuana in the United States (US) has spurred ongoing interest in its clinical application for the management of can…
Phase 1 Open-Label Pilot Trial of H4 Deep Repetitive Transcranial Magnetic Stimulation for Adults With Moderate-to-Severe Cannabis Use Disorder.
Cannabis use disorder (CUD) is a significant public health problem and no medical treatments have received regulatory approval to date. Deep repetitive trans…
Reducing severe breathlessness with dronabinol in the group of patients with severe and very severe chronic obstructive pulmonary disease (BONG): a randomised, double-blinded, placebo-controlled, crossover study in an outpatient clinic in Denmark
Cannabis-based medicine may alleviate breathlessness. This study will investigate whether dronabinol, a synthetic form of ฮ This single-centre, randomised, d…
Medical Cannabis for the Treatment of Peripheral Neuropathy due to Diabetes: A Systematic Review.
This systematic review evaluated randomized controlled trials (RCTs) conducted specifically in participants with diabetes and painful peripheral neuropathy t…
Health-related quality of life in patients receiving medicinal cannabis: systematic review and meta-analysis of primary research findings 2015-2025.
The global burden of chronic health conditions is significant. Medicinal cannabis (MC) is a legalised treatment option for patients with chronic health condi…
The effect of hemp product consumption on blood fatty acid profiles and cardiovascular disease risk factors: results of a randomized, double-blind, crossover clinical trial.
Hemp seeds are high in polyunsaturated fatty acids (PUFAs) including gamma linolenic acid (GLA), stearidonic acid (SDA), alpha linolenic acid (ALA) and linol…
Phase II randomized controlled trial comparing traditional Thai cannabis-based medicine with lorazepam for insomnia treatment.
A traditional Thai cannabis-based multi-herbal formulation is legally recognized in Thailand for therapeutic use and clinical research. However, clinical evi…
Psychosocial Interventions for Substance Use Disorder: A Systematic Review of Therapeutic Approaches and Their Clinical Effectiveness.
Psychosocial interventions are a core component of substance use disorder (SUD) treatment, yet recent evidence remains fragmented across substances, delivery…
Randomized cannabinoid trial reports improvement in chronic pain outcomes #1
A controlled trial examined cannabinoids and pain-related endpoints in adults with chronic symptoms.